Columnist Desiree Lama describes how her pill box became essential as her life with multiple sclerosis meant more and more ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.